Hyderabad: Because of the uncertainty of towering in Afghanistan, Indian pharmaceutical exporter is worried to send goods to a torn country war and the target of exporting pharmaceutical items worth $ 126 million to the country of Taliban now depends on the results of the future.
Udaya Bhaskar, Director General of Pharmacy The Indian Council Export Board (Pharmexcil) Body under the Ministry of Commerce on Tuesday said that the situation was bleak there and Indian pharmaceutical exporter had a friendly relationship with Afghanistan.
“The target projected for 2021-22 is $ 126.22 million.
The majority will be a formulation and after the vaccine.
Now with the current situation, exporter is worried about how the new regime will act.
It is too early to comment.
On the export target, “The official said to PTI on Tuesday.
He, however, said there was no instruction from the center to suspend exports to Afghanistan.
According to statistics supplied by Pharmeexicl, India exported a pharmaceutical product worth $ 90 million and $ 97 to Afghanistan each in 2019-20 and 2020-21 and became the second largest exporter after Pakistan.
Afghanistan has received Pharmacopeia India and medicines produced in India are accepted there, said Udaya Bhaskar.
“A team of officials and Afghan trade representatives visited and held discussions with their colleagues in India in 2019 stemmed friendly relationships,” he said.
The Federation of Indian export organizations (FIEO) Director General of Ajay Sahai recently said domestic exporters must be careful to seek political development in Afghanistan, especially those related to payments, which are adequate credit insurance can be produced by them.
According to a pharmaceutical trade expert, Indian pharmaceutical exports consist of 20 percent vaccine.
Although Afghanistan did not accept all the vaccines needed from India directly, several non-governmental organizations got it from Indian companies and sent them to the country.
Pharmaceutical exporter stares at the uncertainty of Afghanistan; Target $ 126m on the blink
